Biocon Limited — Board Meeting, 07-05-2026: Outcome of Board Meeting

Biocon's board approved audited Q4/FY26 consolidated results. FY26 revenue hit ₹16,927 Cr, profit ₹385.6 Cr. A final dividend of ₹0.50/share was proposed. Board approved acquiring remaining ~2% of Biocon Biologics for ₹330.73 Cr (via shares), aiming for full integration. New directors appointed.